Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Services-Commercial Physical & Biological Research · Wilmington, MA · filing with the SEC since 1999
Grade5.2
◀ Past 6.0● Present 5.1▶ Future 4.1
Filings
226 filings since 2017 beside 727 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-K
Annual report for the fiscal year ending Dec 27, 2026Large accelerated filers have 60 days after the fiscal year ends.
by Feb 25, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 39 days after the quarter ended. The proxy statement was last filed Mar 31, 2026.
Filings a yearinsider forms included
10110289708510780103
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 9 times in the last 36 months, the newest May 11, 2026.SEC letters: 3 in the last 36 months, the newest Dec 5, 2023.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
May 11, 2026
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
May 5, 2026
Jan 13, 2026
8-K items 2.02, 7.01
Results released; Investor disclosure (Regulation FD) · Current report
Sep 16, 2025
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Sep 12, 2025
40 of 226 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.